Delivery Order SPE2DR25D1002-SPE2DR26FGK9P
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 17, 2025, by the Defense Logistics Agency for the supply of Twinrix vaccine in syringe format. The contract represents a firm fixed-price delivery order with a ceiling value of $2,073.96 and an ultimate completion date of November 18, 2025. This award was competitively awarded with no set-aside designation and is a child order issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,153.57 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive, firm fixed-price delivery order was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $1,761.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe form, with a completion deadline of November 4, 2025. The contract, issued on November 3, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,044.58 by the Defense Logistics Agency (DLA) on December 4, 2025, for the supply of Twinrix vaccine in syringe format. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,111.33 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, with completion targeted for November 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,705.28 in Twinrix vaccine syringes on December 9, 2025, with an ultimate completion date of December 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters. This delivery order represents...
- The Defense Logistics Agency awarded a $11,068.93 delivery order to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe form, with an ultimate completion date of September 17, 2025. This contract represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub. This delivery order is issued...
- The Defense Logistics Agency awarded a $25,946.28 delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis without set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $17,246.08 and a firm fixed price structure. This non-competitive delivery order is set to conclude on May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGK9PDelivery Order
The Defense Logistics Agency awarded a $1,296.11 delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's comprehensive Indefinite Delivery Vehicle with DLA Troop Support Medical functions as a global pharmaceutical support platform enabling the delivery of an extensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. The contract awards consistently demonstrate the company's capability to fulfill federal medical supply requirements through open competition, with delivery orders ranging substantially in value and covering diverse therapeutic domains across multiple customer agencies including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/8/25 |